Skip to main content
Top
Published in: BMC Cancer 1/2023

Open Access 01-12-2023 | Liver Resection | Research

An integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer

Authors: Yizhen Fu, Zhenyun Yang, Zili Hu, Zhoutian Yang, Jinbin Chen, Juncheng Wang, Zhongguo Zhou, Li Xu, Minshan Chen, Yaojun Zhang

Published in: BMC Cancer | Issue 1/2023

Login to get access

Abstract

Background

Laparoscopic liver resection (LLR) is now widely performed in treating primary liver cancer (PLC) and yields equal long-term and superior short-term outcomes to those of open liver resection (OLR). The optimal surgical approach for resectable PLC (rPLC) remains controversial. Herein, we aimed to develop a nomogram to determine the most appropriate resection approach for the individual patient.

Methods

Patients with rPLC who underwent hepatectomy from January 2013 to December 2018 were reviewed. Prediction model for risky surgery during LLR was constructed.

Results

A total of 900 patients in the LLR cohort and 423 patients in the OLR cohort were included. A history of previous antitumor treatment, tumor diameter, tumor location and resection extent were independently associated with risky surgery of LLR. The nomogram which was constructed based on these risk factors demonstrated good accuracy in predicting risky surgery with a C index of 0.83 in the development cohort and of 0.76 in the validation cohort. Patients were stratified into high-, medium- or low-risk levels for receiving LLR if the calculated score was more than 0.8, between 0.2 and 0.8 or less than 0.2, respectively. High-risk patients who underwent LLR had more blood loss (441 ml to 417 ml) and a longer surgery time (183 min to 150 min) than those who received OLR.

Conclusions

Patients classified into the high-risk level for LLR instead undergo OLR to reduce surgical risks and complications and patients classified into the low-risk level undergo LLR to maximize the advantages of minimally invasive surgery.

Trial registration

This study was registered in the Chinese Clinical Trial Registry (registration number: ChiCTR2100049446).
Appendix
Available only for authorised users
Literature
1.
go back to reference Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.CrossRefPubMed Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.CrossRefPubMed
2.
go back to reference Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019;394(10204):1145–58.CrossRefPubMedPubMedCentral Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019;394(10204):1145–58.CrossRefPubMedPubMedCentral
3.
go back to reference European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236.CrossRef European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236.CrossRef
4.
go back to reference Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589–604.CrossRefPubMedPubMedCentral Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589–604.CrossRefPubMedPubMedCentral
5.
go back to reference Gigot JF, Glineur D, Santiago Azagra J, Goergen M, Ceuterick M, Morino M, et al. Laparoscopic liver resection for malignant liver tumors: preliminary results of a multicenter European study. Ann Surg. 2002;236(1):90–7.CrossRefPubMedPubMedCentral Gigot JF, Glineur D, Santiago Azagra J, Goergen M, Ceuterick M, Morino M, et al. Laparoscopic liver resection for malignant liver tumors: preliminary results of a multicenter European study. Ann Surg. 2002;236(1):90–7.CrossRefPubMedPubMedCentral
6.
go back to reference Cheung TT, Poon RT, Yuen WK, Chok KS, Jenkins CR, Chan SC, et al. Long-term survival analysis of pure laparoscopic versus open hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a single-center experience. Ann Surg. 2013;257(3):506–11.CrossRefPubMed Cheung TT, Poon RT, Yuen WK, Chok KS, Jenkins CR, Chan SC, et al. Long-term survival analysis of pure laparoscopic versus open hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a single-center experience. Ann Surg. 2013;257(3):506–11.CrossRefPubMed
7.
go back to reference Han HS, Shehta A, Ahn S, Yoon YS, Cho JY, Choi Y. Laparoscopic versus open liver resection for hepatocellular carcinoma: Case-matched study with propensity score matching. J Hepatol. 2015;63(3):643–50.CrossRefPubMed Han HS, Shehta A, Ahn S, Yoon YS, Cho JY, Choi Y. Laparoscopic versus open liver resection for hepatocellular carcinoma: Case-matched study with propensity score matching. J Hepatol. 2015;63(3):643–50.CrossRefPubMed
8.
go back to reference Yoon YI, Kim KH, Kang SH, Kim WJ, Shin MH, Lee SK, et al. Pure Laparoscopic Versus Open Right Hepatectomy for Hepatocellular Carcinoma in Patients With Cirrhosis: A Propensity Score Matched Analysis. Ann Surg. 2017;265(5):856–63.CrossRefPubMed Yoon YI, Kim KH, Kang SH, Kim WJ, Shin MH, Lee SK, et al. Pure Laparoscopic Versus Open Right Hepatectomy for Hepatocellular Carcinoma in Patients With Cirrhosis: A Propensity Score Matched Analysis. Ann Surg. 2017;265(5):856–63.CrossRefPubMed
9.
go back to reference Cheung TT, Dai WC, Tsang SH, Chan AC, Chok KS, Chan SC, et al. Pure Laparoscopic Hepatectomy Versus Open Hepatectomy for Hepatocellular Carcinoma in 110 Patients With Liver Cirrhosis: A Propensity Analysis at a Single Center. Ann Surg. 2016;264(4):612–20.CrossRefPubMed Cheung TT, Dai WC, Tsang SH, Chan AC, Chok KS, Chan SC, et al. Pure Laparoscopic Hepatectomy Versus Open Hepatectomy for Hepatocellular Carcinoma in 110 Patients With Liver Cirrhosis: A Propensity Analysis at a Single Center. Ann Surg. 2016;264(4):612–20.CrossRefPubMed
10.
go back to reference Witowski J, Rubinkiewicz M, Mizera M, Wysocki M, Gajewska N, Sitkowski M, et al. Meta-analysis of short- and long-term outcomes after pure laparoscopic versus open liver surgery in hepatocellular carcinoma patients. Surg Endosc. 2019;33(5):1491–507.CrossRefPubMed Witowski J, Rubinkiewicz M, Mizera M, Wysocki M, Gajewska N, Sitkowski M, et al. Meta-analysis of short- and long-term outcomes after pure laparoscopic versus open liver surgery in hepatocellular carcinoma patients. Surg Endosc. 2019;33(5):1491–507.CrossRefPubMed
11.
go back to reference Goh EL, Chidambaram S, Ma S. Laparoscopic vs open hepatectomy for hepatocellular carcinoma in patients with cirrhosis: A meta-analysis of the long-term survival outcomes. Int J Surg. 2018;50:35–42.CrossRefPubMed Goh EL, Chidambaram S, Ma S. Laparoscopic vs open hepatectomy for hepatocellular carcinoma in patients with cirrhosis: A meta-analysis of the long-term survival outcomes. Int J Surg. 2018;50:35–42.CrossRefPubMed
12.
go back to reference Fretland AA, Dagenborg VJ, Bjornelv GMW, Kazaryan AM, Kristiansen R, Fagerland MW, et al. Laparoscopic Versus Open Resection for Colorectal Liver Metastases: The OSLO-COMET Randomized Controlled Trial. Ann Surg. 2018;267(2):199–207.CrossRefPubMed Fretland AA, Dagenborg VJ, Bjornelv GMW, Kazaryan AM, Kristiansen R, Fagerland MW, et al. Laparoscopic Versus Open Resection for Colorectal Liver Metastases: The OSLO-COMET Randomized Controlled Trial. Ann Surg. 2018;267(2):199–207.CrossRefPubMed
13.
go back to reference Martinez-Cecilia D, Cipriani F, Shelat V, Ratti F, Tranchart H, Barkhatov L, et al. Laparoscopic Versus Open Liver Resection for Colorectal Metastases in Elderly and Octogenarian Patients: A Multicenter Propensity Score Based Analysis of Short- and Long-term Outcomes. Ann Surg. 2017;265(6):1192–200.CrossRefPubMed Martinez-Cecilia D, Cipriani F, Shelat V, Ratti F, Tranchart H, Barkhatov L, et al. Laparoscopic Versus Open Liver Resection for Colorectal Metastases in Elderly and Octogenarian Patients: A Multicenter Propensity Score Based Analysis of Short- and Long-term Outcomes. Ann Surg. 2017;265(6):1192–200.CrossRefPubMed
14.
go back to reference Wu J, Han J, Zhang Y, Liang L, Zhao J, Han F, et al. Safety and feasibility of laparoscopic versus open liver resection with associated lymphadenectomy for intrahepatic cholangiocarcinoma. Biosci Trends. 2020;14(5):376–83.CrossRefPubMed Wu J, Han J, Zhang Y, Liang L, Zhao J, Han F, et al. Safety and feasibility of laparoscopic versus open liver resection with associated lymphadenectomy for intrahepatic cholangiocarcinoma. Biosci Trends. 2020;14(5):376–83.CrossRefPubMed
15.
go back to reference Hobeika C, Cauchy F, Fuks D, Barbier L, Fabre JM, Boleslawski E, et al. Laparoscopic versus open resection of intrahepatic cholangiocarcinoma: nationwide analysis. Br J Surg. 2021;108(4):419–26.CrossRefPubMed Hobeika C, Cauchy F, Fuks D, Barbier L, Fabre JM, Boleslawski E, et al. Laparoscopic versus open resection of intrahepatic cholangiocarcinoma: nationwide analysis. Br J Surg. 2021;108(4):419–26.CrossRefPubMed
16.
go back to reference Abu Hilal M, Aldrighetti L, Dagher I, Edwin B, Troisi RI, Alikhanov R, et al. The Southampton Consensus Guidelines for Laparoscopic Liver Surgery: From Indication to Implementation. Ann Surg. 2018;268(1):11–8.CrossRefPubMed Abu Hilal M, Aldrighetti L, Dagher I, Edwin B, Troisi RI, Alikhanov R, et al. The Southampton Consensus Guidelines for Laparoscopic Liver Surgery: From Indication to Implementation. Ann Surg. 2018;268(1):11–8.CrossRefPubMed
17.
go back to reference Zhou J, Sun H, Wang Z, Cong W, Wang J, Zeng M, et al. Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition). Liver Cancer. 2020;9(6):682–720.CrossRefPubMedPubMedCentral Zhou J, Sun H, Wang Z, Cong W, Wang J, Zeng M, et al. Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition). Liver Cancer. 2020;9(6):682–720.CrossRefPubMedPubMedCentral
18.
go back to reference Schindl MJ, Redhead DN, Fearon KC, Garden OJ, Wigmore SJ, Edinburgh Liver S, et al. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut. 2005;54(2):289–96.CrossRefPubMedPubMedCentral Schindl MJ, Redhead DN, Fearon KC, Garden OJ, Wigmore SJ, Edinburgh Liver S, et al. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut. 2005;54(2):289–96.CrossRefPubMedPubMedCentral
19.
go back to reference van Mierlo KM, Schaap FG, Dejong CH, OldeDamink SW. Liver resection for cancer: New developments in prediction, prevention and management of postresectional liver failure. J Hepatol. 2016;65(6):1217–31.CrossRefPubMed van Mierlo KM, Schaap FG, Dejong CH, OldeDamink SW. Liver resection for cancer: New developments in prediction, prevention and management of postresectional liver failure. J Hepatol. 2016;65(6):1217–31.CrossRefPubMed
20.
go back to reference Strasberg SM, Phillips C. Use and dissemination of the brisbane 2000 nomenclature of liver anatomy and resections. Ann Surg. 2013;257(3):377–82.CrossRefPubMed Strasberg SM, Phillips C. Use and dissemination of the brisbane 2000 nomenclature of liver anatomy and resections. Ann Surg. 2013;257(3):377–82.CrossRefPubMed
21.
go back to reference Ban D, Tanabe M, Ito H, Otsuka Y, Nitta H, Abe Y, et al. A novel difficulty scoring system for laparoscopic liver resection. J Hepatobiliary Pancreat Sci. 2014;21(10):745–53.CrossRefPubMed Ban D, Tanabe M, Ito H, Otsuka Y, Nitta H, Abe Y, et al. A novel difficulty scoring system for laparoscopic liver resection. J Hepatobiliary Pancreat Sci. 2014;21(10):745–53.CrossRefPubMed
22.
go back to reference Halls MC, Berardi G, Cipriani F, Barkhatov L, Lainas P, Harris S, et al. Development and validation of a difficulty score to predict intraoperative complications during laparoscopic liver resection. Br J Surg. 2018;105(9):1182–91.CrossRefPubMed Halls MC, Berardi G, Cipriani F, Barkhatov L, Lainas P, Harris S, et al. Development and validation of a difficulty score to predict intraoperative complications during laparoscopic liver resection. Br J Surg. 2018;105(9):1182–91.CrossRefPubMed
23.
go back to reference Jang JS, Cho JY, Ahn S, Han HS, Yoon YS, Choi Y, et al. Comparative Performance of the Complexity Classification and the Conventional Major/Minor Classification for Predicting the Difficulty of Liver Resection for Hepatocellular Carcinoma. Ann Surg. 2018;267(1):18–23.CrossRefPubMed Jang JS, Cho JY, Ahn S, Han HS, Yoon YS, Choi Y, et al. Comparative Performance of the Complexity Classification and the Conventional Major/Minor Classification for Predicting the Difficulty of Liver Resection for Hepatocellular Carcinoma. Ann Surg. 2018;267(1):18–23.CrossRefPubMed
24.
go back to reference Lee MKt, Gao F, Strasberg SM. Perceived complexity of various liver resections: results of a survey of experts with development of a complexity score and classification. J Am Coll Surg. 2015;220(1):64–9.CrossRefPubMed Lee MKt, Gao F, Strasberg SM. Perceived complexity of various liver resections: results of a survey of experts with development of a complexity score and classification. J Am Coll Surg. 2015;220(1):64–9.CrossRefPubMed
25.
go back to reference Lee MKt, Gao F, Strasberg SM. Completion of a liver surgery complexity score and classification based on an international survey of experts. J Am Coll Surg. 2016;223(2):332–42.CrossRefPubMedPubMedCentral Lee MKt, Gao F, Strasberg SM. Completion of a liver surgery complexity score and classification based on an international survey of experts. J Am Coll Surg. 2016;223(2):332–42.CrossRefPubMedPubMedCentral
26.
go back to reference Buell JF, Cherqui D, Geller DA, O’Rourke N, Iannitti D, Dagher I, et al. The international position on laparoscopic liver surgery: The Louisville Statement, 2008. Ann Surg. 2009;250(5):825–30.CrossRefPubMed Buell JF, Cherqui D, Geller DA, O’Rourke N, Iannitti D, Dagher I, et al. The international position on laparoscopic liver surgery: The Louisville Statement, 2008. Ann Surg. 2009;250(5):825–30.CrossRefPubMed
27.
go back to reference Kerr KF, Brown MD, Zhu K, Janes H. Assessing the clinical impact of risk prediction models with decision curves: guidance for correct interpretation and appropriate use. J Clin Oncol. 2016;34(21):2534–40.CrossRefPubMedPubMedCentral Kerr KF, Brown MD, Zhu K, Janes H. Assessing the clinical impact of risk prediction models with decision curves: guidance for correct interpretation and appropriate use. J Clin Oncol. 2016;34(21):2534–40.CrossRefPubMedPubMedCentral
28.
go back to reference Ding G, Cai W, Qin M. Pure laparoscopic versus open liver resection in treatment of hepatolithiasis within the left lobes: a randomized trial study. Surg Laparosc Endosc Percutan Tech. 2015;25(5):392–4.CrossRefPubMed Ding G, Cai W, Qin M. Pure laparoscopic versus open liver resection in treatment of hepatolithiasis within the left lobes: a randomized trial study. Surg Laparosc Endosc Percutan Tech. 2015;25(5):392–4.CrossRefPubMed
29.
go back to reference Zheng H, Huang SG, Qin SM, Xiang F. Comparison of laparoscopic versus open liver resection for lesions located in posterosuperior segments: a meta-analysis of short-term and oncological outcomes. Surg Endosc. 2019;33(12):3910–8.CrossRefPubMed Zheng H, Huang SG, Qin SM, Xiang F. Comparison of laparoscopic versus open liver resection for lesions located in posterosuperior segments: a meta-analysis of short-term and oncological outcomes. Surg Endosc. 2019;33(12):3910–8.CrossRefPubMed
30.
31.
go back to reference Yamagishi S, Midorikawa Y, Nakayama H, Higaki T, Moriguchi M, Aramaki O, et al. Liver resection for recurrent hepatocellular carcinoma after radiofrequency ablation therapy. Hepatol Res. 2019;49(4):432–40.CrossRefPubMed Yamagishi S, Midorikawa Y, Nakayama H, Higaki T, Moriguchi M, Aramaki O, et al. Liver resection for recurrent hepatocellular carcinoma after radiofrequency ablation therapy. Hepatol Res. 2019;49(4):432–40.CrossRefPubMed
32.
go back to reference Yamashita S, Aoki T, Inoue Y, Kaneko J, Sakamoto Y, Sugawara Y, et al. Outcome of salvage hepatic resection for recurrent hepatocellular carcinoma after radiofrequency ablation therapy. Surgery. 2015;157(3):463–72.CrossRefPubMed Yamashita S, Aoki T, Inoue Y, Kaneko J, Sakamoto Y, Sugawara Y, et al. Outcome of salvage hepatic resection for recurrent hepatocellular carcinoma after radiofrequency ablation therapy. Surgery. 2015;157(3):463–72.CrossRefPubMed
33.
go back to reference Song KD, Lim HK, Rhim H, Lee MW, Kim YS, Lee WJ, et al. Repeated hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma after hepatic resection: a propensity score matching study. Radiology. 2015;275(2):599–608.CrossRefPubMed Song KD, Lim HK, Rhim H, Lee MW, Kim YS, Lee WJ, et al. Repeated hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma after hepatic resection: a propensity score matching study. Radiology. 2015;275(2):599–608.CrossRefPubMed
34.
go back to reference Zhou WP, Lai EC, Li AJ, Fu SY, Zhou JP, Pan ZY, et al. A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma. Ann Surg. 2009;249(2):195–202.CrossRefPubMed Zhou WP, Lai EC, Li AJ, Fu SY, Zhou JP, Pan ZY, et al. A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma. Ann Surg. 2009;249(2):195–202.CrossRefPubMed
35.
go back to reference Kawaguchi Y, Fuks D, Kokudo N, Gayet B. Difficulty of Laparoscopic Liver Resection: Proposal for a New Classification. Ann Surg. 2018;267(1):13–7.CrossRefPubMed Kawaguchi Y, Fuks D, Kokudo N, Gayet B. Difficulty of Laparoscopic Liver Resection: Proposal for a New Classification. Ann Surg. 2018;267(1):13–7.CrossRefPubMed
36.
go back to reference Cheung TT, Han HS, She WH, Chen KH, Chow PKH, Yoong BK, et al. The Asia Pacific consensus statement on laparoscopic liver resection for hepatocellular carcinoma: a report from the 7th asia-pacific primary liver cancer expert meeting held in Hong Kong. Liver Cancer. 2018;7(1):28–39.CrossRefPubMed Cheung TT, Han HS, She WH, Chen KH, Chow PKH, Yoong BK, et al. The Asia Pacific consensus statement on laparoscopic liver resection for hepatocellular carcinoma: a report from the 7th asia-pacific primary liver cancer expert meeting held in Hong Kong. Liver Cancer. 2018;7(1):28–39.CrossRefPubMed
Metadata
Title
An integrated strategy for deciding open versus laparoscopic hepatectomy for resectable primary liver cancer
Authors
Yizhen Fu
Zhenyun Yang
Zili Hu
Zhoutian Yang
Jinbin Chen
Juncheng Wang
Zhongguo Zhou
Li Xu
Minshan Chen
Yaojun Zhang
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2023
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-10630-x

Other articles of this Issue 1/2023

BMC Cancer 1/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine